Table 4 Nasal carriage of MRS and MDRS for the personnel studied by horse intended use

Human subjects [n]

1

11

10

13

34

Human subjects with MRS [n]

1

8

1

2

11

Prevalence of human nasal MRS carriage (95% CI)

1.00

(1.00–1.00)

0.73

(0.31, 0.94)

0.10

(0.01, 0.48)

0.15

(0.03, 0.48)

0.32

(0.16–0.55)

Prevalence ratio for human nasal MRS carriage [PR (95% CI)]

–

4.72 (1.21, 18.40)

0.65 (0.07, 5.80)

1.00

–

Human subjects with MDRS [n]

1

5

0

1

6

Prevalence of human nasal MDRS carriage (95% CI)

1.00

(1.00, 1.00)

0.45

(0.17, 0.77)

0.00

(0.00, 0.00)

0.077

(0.01, 0.41)

0.18

(0.07–0.38)

Prevalence ratio for human nasal MDRS carriage [PR (95% CI)]

–

5.91 (0.81, 43.11)

0.00 (0.00, 0.00)

1.00

–